Bortezomib Related Products
Axios Research stands at the forefront of pharmaceutical reference standards ingenuity, providing high quality Bortezomib Reference Standards. These include both pharmacopeial and non-pharmacopeial Bortezomib impurities, metabolites, stable isotope products, and nitrosamines. Our Bortezomib impurity reference standards are essential for pharmaceutical research, aiding in product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They are also used in identifying unknown impurities and evaluating genotoxic potential. Our Bortezomib related products are meticulously characterized and come with a comprehensive Certificates of Analysis (COA) and analytical data that comply with regulatory standards.
(R)-(1-amino-3-methylbutyl)boronic acid hydrochloride
M.F. C₅H₁₄BNO₂. HCl
M.W. 130.98 36.46
CAT# AR-B01899
CAS# 1158974-93-6
((R)-3-Hydroxy-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
M.F. C₁₉H₂₅BN₄O₅
M.W. 400.25
CAT# AR-B05560
CAS# NA
Bortezomib Impurity ((S)-3-Phenyl-2- (pyrazine-2-carbonylamino) propanoic Acid)
M.F. C₁₄H₁₃N₃O₃
M.W. 271.28
CAT# AR-B01842
CAS# 114457-94-2
Bortezomib Impurity (Mixture of (1S,2R)-Isomer and (1R,2R)-Isomer)
M.F. C₁₉H₂₄N₄O₃
M.W. 356.43
CAT# AR-B01869
CAS# 2747958-64-9
Bortezomib Mixture of Isomer (SS and RR, 1:1)
M.F. C₁₉H₂₅BN₄O₄
M.W. 384.2
CAT# AR-B08224
CAS# 1132709-15-9 + 1132709-14-8
